FARE Thanks Delaware House Committee for Passing Country’s First Early Introduction Bill
HB 274 Could Reverse the Rise of Food Allergies in Delaware
McLean, VA – March 20, 2024: Today, FARE applauded the effort of Delaware State House Rep. Kimberly Williams (D-19) for championing HB 274 and yesterday’s historic vote by the House Economic Development/Banking/Insurance & Commerce Committee for unanimously passing the country’s first early introduction bill.
If passed into law, HB 274 would provide all Delaware parents, at no cost, including those on Medicaid with at least one peanut and one egg infant-safe food allergen supplement to feed their infants starting at four to six months of age to reverse the rise of these food allergies by preventing them from developing in the first place. While the CDC estimates that nearly 8% of all children have food allergies, the historic LEAP and EAT studies demonstrated the power of introducing known allergens—peanut and egg—to infants at a young age to prevent them from becoming allergic to these foods.
FARE endorsed HB 274, and yesterday, both Dr. Kelly Cleary, FARE’s Director of Education & Support Programs; and Jason Linde, our Senior Vice President of Advocacy, and former Delaware resident, testified in Dover in support of the legislation.
Said Linde, “On behalf of the more than 104,000 food allergy families in Delaware, FARE is grateful for Rep. Williams’ leadership and the historic vote yesterday by members of the House Economic Development/Banking/Insurance & Commerce Committee in passing HB 274. We are going to do everything possible to ensure that this bill ends up on the Governor’s desk later this year and becomes signed into law.”
If signed into law, HB 274 would go into effect on January 1, 2026.
Media Contact:
About FARE
FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.